Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[DHEA: an unknown star].

J L Schlienger1, A E Perrin, B Goichot

  • 1Service de médecine interne et nutrition, hôpital de Hautepierre, 67098 Strasbourg, France. Jean-Louis.Schlienger@chru-strasbourg.fr

La Revue De Medecine Interne
|June 18, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort study.

International journal of surgery (London, England)·2024
Same author

Controversy: Pros and cons screening of corticotropic deficiency after exogenous glucocorticoid therapy.

Annales d'endocrinologie·2018
Same author

Subclinical haemorrhage in non-functional adenomas.

Neuro-Chirurgie·2018
Same author

An unusual pituitary stalk lesion: What is the place of surgery?

Neuro-Chirurgie·2017
Same author

Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study.

European journal of endocrinology·2015
Same author

Clinical presentation of hyperthyroidism in a large representative sample of outpatients in France: relationships with age, aetiology and hormonal parameters.

Clinical endocrinology·2015
Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026
Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026
Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026
Same journal

Heart involvements in systemic sclerosis beyond pulmonary hypertension: From conduction, rhythm and function defects to coronary artery disease.

La Revue de medecine interne·2026
Same journal

[Acute intermittent porphyria: When diagnostic errance jeopardizes patient health].

La Revue de medecine interne·2026
Same journal

Autosomal dominant polycystic kidney disease: Current perspectives in 2026.

La Revue de medecine interne·2026
See all related articles

Dehydroepiandrosterone (DHEA) supplementation shows limited proven benefits for aging, despite age-related decline. Further research is needed to confirm its effects on well-being and inflammation.

Area of Science:

  • Endocrinology and Metabolism
  • Neuroendocrinology

Context:

  • Dehydroepiandrosterone (DHEA) is the most abundant human plasma steroid, acting as an androgenic and estrogenic precursor and a neurosteroid.
  • DHEA shows promise in animal models for metabolic diseases, obesity, insulin resistance, immunomodulation, and cognitive enhancement.
  • Human evidence for DHEA's efficacy in pathologies is limited, except for adrenal insufficiency and potentially severe systemic lupus erythematosus.

Purpose:

  • To elucidate the physiological functions of dehydroepiandrosterone (DHEA).
  • To analyze the potential benefits of DHEA supplementation for mitigating age-related decline and enhancing well-being.

Summary:

  • DHEA supplementation has inconsistent effects on well-being in post-menopausal women and is not a proven anti-aging solution.

Related Experiment Videos

  • While DHEA is linked to aging-related decline, its role in cardiovascular or cancer risk is unproven.
  • Adrenal insufficiency remains the primary indication for oral DHEA supplementation; its potential for androgen replacement in menopausal men warrants further study.

    • Impact:

    • Highlights the need for rigorous, large-scale prospective studies to establish the true benefits and risks of DHEA for aging prevention.
    • Underscores the necessity of further investigation into DHEA's anti-inflammatory and immunomodulatory properties.
    • Provides a balanced perspective on DHEA's current therapeutic applications and future research directions.